Search

Patrick T. Lewis

Examiner (ID: 16456, Phone: (571)272-0655 , Office: P/1672 )

Most Active Art Unit
1623
Art Unit(s)
1623, 1621, 1693, 1691, 1672, 1673
Total Applications
1936
Issued Applications
1309
Pending Applications
238
Abandoned Applications
439

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16360917 [patent_doc_number] => 20200317668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => METHOD OF INHIBITING OR REDUCING A CORONAVIRIDAE VIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 16/909394 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79739 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909394 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/909394
Method of inhibiting or reducing a viral infection Jun 22, 2020 Issued
Array ( [id] => 18604673 [patent_doc_number] => 11746123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-05 [patent_title] => Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof [patent_app_type] => utility [patent_app_number] => 16/908416 [patent_app_country] => US [patent_app_date] => 2020-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 144087 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1803 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16908416 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/908416
Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof Jun 21, 2020 Issued
Array ( [id] => 17790438 [patent_doc_number] => 20220249529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS FOR TREATING LEUKEMIA OR MYELODYSPLASTIC SYNDROME [patent_app_type] => utility [patent_app_number] => 17/620545 [patent_app_country] => US [patent_app_date] => 2020-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29286 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620545 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/620545
Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome Jun 18, 2020 Issued
Array ( [id] => 17913222 [patent_doc_number] => 20220315617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => Crosslinked Nucleoside Intermediate Crystal And Method For Producing Same, And Method For Producing Crosslinked Nucleoside Amidite [patent_app_type] => utility [patent_app_number] => 17/608780 [patent_app_country] => US [patent_app_date] => 2020-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10439 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17608780 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/608780
Crosslinked nucleoside intermediate crystal and method for producing same, and method for producing crosslinked nucleoside amidite Jun 17, 2020 Issued
Array ( [id] => 17890744 [patent_doc_number] => 11453697 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-09-27 [patent_title] => Cyclic di-nucleotide compounds as sting agonists [patent_app_type] => utility [patent_app_number] => 16/904888 [patent_app_country] => US [patent_app_date] => 2020-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62182 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904888 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/904888
Cyclic di-nucleotide compounds as sting agonists Jun 17, 2020 Issued
Array ( [id] => 17882719 [patent_doc_number] => 20220298196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => NOVEL COMPOUND DERIVED FROM WATERMELON, AND COMPOSITION USING SAME [patent_app_type] => utility [patent_app_number] => 17/619081 [patent_app_country] => US [patent_app_date] => 2020-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5378 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17619081 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/619081
Compound derived from watermelon, and composition using same Jun 16, 2020 Issued
Array ( [id] => 16326728 [patent_doc_number] => 20200297693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-24 [patent_title] => GLUCOSE CONJUGATES OF TRIPTOLIDE, ANALOGS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/899226 [patent_app_country] => US [patent_app_date] => 2020-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2733 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899226 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/899226
GLUCOSE CONJUGATES OF TRIPTOLIDE, ANALOGS AND USES THEREOF Jun 10, 2020 Abandoned
Array ( [id] => 17769367 [patent_doc_number] => 11401294 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-02 [patent_title] => Co-crystal forms of a novobiocin analog and proline [patent_app_type] => utility [patent_app_number] => 16/894461 [patent_app_country] => US [patent_app_date] => 2020-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 21115 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16894461 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/894461
Co-crystal forms of a novobiocin analog and proline Jun 4, 2020 Issued
Array ( [id] => 17928343 [patent_doc_number] => 20220323468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => REDUCED NICOTINAMIDERIBOSIDES FOR THE TREATMENT/PREVENTION OF LIVER DISEASE [patent_app_type] => utility [patent_app_number] => 17/595984 [patent_app_country] => US [patent_app_date] => 2020-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6246 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595984 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/595984
REDUCED NICOTINAMIDERIBOSIDES FOR THE TREATMENT/PREVENTION OF LIVER DISEASE Jun 2, 2020 Pending
Array ( [id] => 17805789 [patent_doc_number] => 20220257624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE [patent_app_type] => utility [patent_app_number] => 17/614055 [patent_app_country] => US [patent_app_date] => 2020-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5251 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614055 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/614055
COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE May 31, 2020 Pending
Array ( [id] => 16312317 [patent_doc_number] => 20200291055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => Methods of Preparing Nicotinamide Riboside and Derivatives Thereof [patent_app_type] => utility [patent_app_number] => 16/886985 [patent_app_country] => US [patent_app_date] => 2020-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8005 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16886985 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/886985
Methods of preparing nicotinamide riboside and derivatives thereof May 28, 2020 Issued
Array ( [id] => 20414197 [patent_doc_number] => 12497467 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-16 [patent_title] => Recycle content cellulose ester [patent_app_type] => utility [patent_app_number] => 17/595565 [patent_app_country] => US [patent_app_date] => 2020-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 25 [patent_no_of_words] => 82234 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595565 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/595565
Recycle content cellulose ester May 21, 2020 Issued
Array ( [id] => 20414197 [patent_doc_number] => 12497467 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-16 [patent_title] => Recycle content cellulose ester [patent_app_type] => utility [patent_app_number] => 17/595565 [patent_app_country] => US [patent_app_date] => 2020-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 25 [patent_no_of_words] => 82234 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595565 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/595565
Recycle content cellulose ester May 21, 2020 Issued
Array ( [id] => 17890741 [patent_doc_number] => 11453694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-27 [patent_title] => Glycosyl hesperetin and process for producing the same and uses thereof [patent_app_type] => utility [patent_app_number] => 16/878911 [patent_app_country] => US [patent_app_date] => 2020-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19932 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878911 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/878911
Glycosyl hesperetin and process for producing the same and uses thereof May 19, 2020 Issued
Array ( [id] => 16391005 [patent_doc_number] => 20200331946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-22 [patent_title] => PROCESSES FOR THE PREPARATION OF SGLT-2 INHIBITORS, INTERMEDIATES THEREOF [patent_app_type] => utility [patent_app_number] => 16/876659 [patent_app_country] => US [patent_app_date] => 2020-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8333 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 289 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16876659 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/876659
Processes for the preparation of SGLT-2 inhibitors, intermediates thereof May 17, 2020 Issued
Array ( [id] => 19870346 [patent_doc_number] => 12263184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-01 [patent_title] => Materials and methods for producing arabinoxylan compositions [patent_app_type] => utility [patent_app_number] => 17/609684 [patent_app_country] => US [patent_app_date] => 2020-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24906 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609684 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/609684
Materials and methods for producing arabinoxylan compositions May 7, 2020 Issued
Array ( [id] => 17720578 [patent_doc_number] => 20220213298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => POROUS CELLULOSE MICROPARTICLES AND METHODS OF MANUFACTURE THEREOF [patent_app_type] => utility [patent_app_number] => 17/610121 [patent_app_country] => US [patent_app_date] => 2020-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22564 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610121 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/610121
POROUS CELLULOSE MICROPARTICLES AND METHODS OF MANUFACTURE THEREOF May 5, 2020 Abandoned
Array ( [id] => 16720071 [patent_doc_number] => 20210087218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => COMPOSITIONS AND METHODS DIRECTED TO TREATING LIVER FIBROSIS [patent_app_type] => utility [patent_app_number] => 16/868010 [patent_app_country] => US [patent_app_date] => 2020-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868010 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/868010
COMPOSITIONS AND METHODS DIRECTED TO TREATING LIVER FIBROSIS May 5, 2020 Abandoned
Array ( [id] => 16450987 [patent_doc_number] => 20200360413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => Composition and Methods of Treating Acne and Photoaging [patent_app_type] => utility [patent_app_number] => 16/860768 [patent_app_country] => US [patent_app_date] => 2020-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10774 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860768 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/860768
Composition and methods of treating acne and photoaging Apr 27, 2020 Issued
Array ( [id] => 16806041 [patent_doc_number] => 20210128594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY DISORDERS [patent_app_type] => utility [patent_app_number] => 16/854196 [patent_app_country] => US [patent_app_date] => 2020-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8148 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854196 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/854196
Compositions and methods for treatment of inflammatory disorders Apr 20, 2020 Issued
Menu